Severe aquaporin-4 IgG-positive neuromyelitis optica spectrum disorder with short myelitis lesion and favourable outcome

Neurol Sci. 2015 Oct;36(10):1925-7. doi: 10.1007/s10072-015-2277-z. Epub 2015 Jun 7.

Authors

Gianni Masi¹, Chiara Cioni¹, Umberto Arrigucci², Alfonso Cerase², Pasquale Annunziata³

Affiliations

¹ Department of Medicine, Surgery and Neurosciences, Clinical Neuroimmunology Unit, University of Siena, Siena, Italy.
² Unit of Neuroimaging and Neurointervention, Medical School, Siena, Italy.
³ Department of Medicine, Surgery and Neurosciences, Clinical Neuroimmunology Unit, University of Siena, Siena, Italy. annunziata@unisi.it.

PMID: 26050233
DOI: 10.1007/s10072-015-2277-z

No abstract available

Keywords: Aquaporin-4; Aquaporin-4 IgG; Autoimmunity; Neuromyelitis optica; Neuromyelitis optica spectrum disorder; Transverse myelitis.

Publication types

Case Reports
Letter

MeSH terms

Anti-Inflammatory Agents / therapeutic use
Aquaporin 4 / immunology*
Female
Humans
Immunoglobulin G / blood*
Magnetic Resonance Imaging
Methylprednisolone / therapeutic use
Myelitis / complications*
Myelitis / drug therapy
Neuromyelitis Optica / complications*
Neuromyelitis Optica / drug therapy
Neuromyelitis Optica / immunology
Treatment Outcome*
Young Adult

Substances

AQP4 protein, human
Anti-Inflammatory Agents
Aquaporin 4
Immunoglobulin G
Methylprednisolone